Subtype
Benign Vascular Neoplasm
CI-CAN-00000556Explore in graph →
Non-malignant13 active trials1 evidence items
- NCIt
- C7389
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000556Explore in graph →
Clinical trials
97 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06677853 | Timolol Maleate Gel for the Treatment of Infantile Hemangioma | completed | Phase 2 / Phase 3 | 168 | Auson Pharmaceuticals Inc.INDUSTRY | 1 | Nov 7, 2024 | clinicaltrials |
| NCT01685398 | Topical Timolol for Superficial Infantile Hemangioma | completed | Phase 3 | 48 | Mahidol UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT02342275 |
| Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma |
| completed |
| Phase 3 |
| 377 |
| West China HospitalOTHER |
| 1 |
| Jun 16, 2022 |
| clinicaltrials |
| NCT02505971 | Nadolol Versus Propranolol in Children With Infantile Hemangiomas | completed | Phase 3 | 74 | The Hospital for Sick ChildrenOTHER | 1 | Oct 28, 2020 | clinicaltrials |
| NCT00312520 | Pulse Steroids Versus Oral Steroids in Problematic Hemangiomas of Infancy | completed | Phase 3 | 20 | The Hospital for Sick ChildrenOTHER | 1 | Apr 19, 2018 | clinicaltrials |
| NCT01056341 | Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy | completed | Phase 2 / Phase 3 | 512 | Pierre Fabre DermatologyINDUSTRY | 16 | Dec 10, 2015 | clinicaltrials |
Data updated 22 days agoSource updated Nov 7, 2024source: clinicaltrials